Theravance Biopharma, Inc. Earnings Per Share Diluted

Quick Answer

Theravance Biopharma, Inc. reported Earnings Per Share Diluted of $2.06 per share for the year ending 2025.

  • Theravance Biopharma, Inc. showed an increase of +279.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Theravance Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Theravance Biopharma, Inc.'s Earnings Per Share Diluted has grown by 148.5%.
  • Historical annual values: Fiscal year 2025: $2.06 per share | Fiscal year 2024: $1.15 (loss) per share | Fiscal year 2023: $1.00 (loss) per share | Fiscal year 2022: $11.85 per share | Fiscal year 2021: $2.87 (loss) per share | Fiscal year 2020: $4.46 (loss) per share | Fiscal year 2019: $4.25 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: